Skip to content
  • Thursday, 5 November 2026
  • 8:02 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Oct 26, 2026 0

In a decisive regulatory move aimed at curbing the proliferation of high-potency, synthetic psychoactive substances, the U.S. Drug Enforcement Administration…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Oct 12, 2026 0

In a decisive move to address the burgeoning public health risks associated with the proliferation of synthetic, highly potent derivatives…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Oct 4, 2026 0

The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of semi-synthetic alkaloids…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 26, 2026 0

The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of synthetic alkaloids…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 19, 2026 0

The United States Drug Enforcement Administration (DEA) has officially moved to curtail the proliferation of highly potent, synthetic derivatives associated…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 12, 2026 0

In a significant move to address the rising proliferation of potent, lab-engineered substances, the U.S. Drug Enforcement Administration (DEA) has…

Read More
Clinical Diagnostics & Pathology

Clinical Laboratories Bolster National Disease Surveillance Amidst Temporary CDC Testing Halt

Reynand Amr Wu Apr 25, 2026 0

A temporary cessation of infectious disease testing services at the Centers for Disease Control and Prevention (CDC) has ignited a…

Read More
Yale Research Unveils Molecular Mechanism Behind Sperm-Egg Fusion Interference and Its Potential for Reproductive MedicineEvogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseasesThe Silent Struggle of the Bumblebee: Pesticide Exposure Disrupts Vital Reproduction at the Molecular LevelFive Powerful Python Decorators for Building Robust AI Agents in Production Environments
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial CancerThe Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026
Molecular & Cell Biology
The Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
Angie Faith Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ